TurboSBIR will soon be integrated into the broader TurboInnovate platform, please feel free to reach out with any questions or concerns. Sign up for TurboInnovate at https://turboinnovate.com

Your startup fueled by up to $2.3million of NIH Funding …Without giving up equity or taking on debt

No debt incurred ● No equity lost ● Choose TurboSBIR!

Stay In The Loop!

required
required
required
required
required

Discover Funded Topics

Explore and discover Topics Funded by the NIH to see if you should apply

Funded Topics
BiochemistryBiotechnologyMolecular Biology
Synthetic BiologyHealth SciencesInformatics
Digital HealthMobile HealthTelehealth
Life SciencesClinical Research and Early Clinical Trials(Bio)Engineering in Medicine
Immunology and Immuno-OncologyPhysics in Medicine Neurosciences
NeurobiologyPsychology Social Sciences
All other areas of healthcare
For more informations on topics, visit here
About the NIH

NIH (National Institutes of Health)'s SBIR (R43/R44) and STTR (R41/R42) programs invest over $1B into health and life science companies that are creating innovative technologies that align with NIH (National Institutes of Health)'s mission to improve health and save lives. Several institutional centers (ICs) such as NCATS, NCI, NIBIB, NIDDK, NIA, NIGMS, NIMH, NINR, etc. all participate and welcome proposals. A key objective is to translate promising technologies to the private sector and enable life-saving innovations to reach consumer markets.

about
 
funding
 
Funding Opportunities

Phase I feasibility studies offer startups up to $300K of funding over 6-12 months, depending on the area of healthcare being focused upon. At the completion of the Phase I period, the company may compete for Phase II funding.

Phase II requires that the company has demonstrated feasibility of their work and is ready to for field testing (such as human trials or similar pre-commercialization testing). About $1.9M in funding can be requested for this phase.

Fast-Track (Phase I + Phase II) requires that both Phase I and Phase II applications are submitted and reviewed together as one application to reduce or eliminate the funding gap between phases.

Direct-to-Phase II (D2P2) is meant for small businesses that have already demonstrated substantial scientific and technical merit and feasibility but have not received a Phase I SBIR or STTR for that project.

Startup Success Stories​
Start Applying​
A platform to find and fund innovation across America

Products
Government funds for R&D in tech and life sciences startups.

Our TeamNews & UpdatesContact UsJoin Our Newsletter
hello@omnisync.io
Copyright © OmniSync Incorporated 2025.